Metabolic Adaptation to Tyrosine Kinase Inhibition in Leukemia Stem Cells

Researchers performed a comprehensive evaluation of metabolic adaptation to tyrosine kinase inhibitor treatment and its role in chronic myelogenous leukemia hematopoietic stem and progenitor cell persistence.

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News